Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2654

Actual shortage: 249 (9%)
Anticipated shortage: 0 (0%)
Avoided shortage: 9 (0%)
Resolved: 2396 (90%)

Discontinuation Reports

250

To be discontinued: 3 (1%)
Discontinued: 247 (99%)
Reversed: 0 (0%)

Late reports

329 (11%)

Overdue reports

23 (9%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Resolved 2019-07-02 2021-01-28 88183
TEVA-DULOXETINE 60MG CAPSULE (DELAYED RELEASE) Resolved 2020-10-22 2021-01-28 126936
TEVA-DULOXETINE 30MG CAPSULE (DELAYED RELEASE) Resolved 2020-10-30 2021-03-18 127613
TEVA-DULOXETINE 60MG CAPSULE (DELAYED RELEASE) Resolved 2021-02-11 2021-03-11 133779
TEVA-DULOXETINE 30MG CAPSULE (DELAYED RELEASE) Resolved 2021-04-21 2021-07-29 137885
TEVA-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Resolved 2021-08-27 2023-07-05 144747
TEVA-DULOXETINE 30MG CAPSULE (DELAYED RELEASE) Resolved 2021-09-02 2021-12-02 145106
TEVA-LANSOPRAZOLE 15MG CAPSULE (DELAYED RELEASE) Actual shortage 2021-09-16 2024-03-18 145783
TEVA-DULOXETINE 60MG CAPSULE (DELAYED RELEASE) Resolved 2021-09-30 2021-10-21 146437
TEVA-DULOXETINE 60MG CAPSULE (DELAYED RELEASE) Resolved 2022-01-13 2022-02-17 152685
TEVA-DULOXETINE 30MG CAPSULE (DELAYED RELEASE) Resolved 2022-02-17 2023-02-09 155140
TEVA-DULOXETINE 30MG CAPSULE (DELAYED RELEASE) Resolved 2022-04-21 2022-10-29 159186
TEVA-DULOXETINE 60MG CAPSULE (DELAYED RELEASE) Resolved 2022-09-30 2022-10-18 170776
TEVA-LANSOPRAZOLE 15MG CAPSULE (DELAYED RELEASE) Resolved 2023-06-16 2023-07-06 195036
TEVA-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Actual shortage 2023-06-19 2024-03-18 195649
TEVA-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Actual shortage 2023-06-20 2024-03-18 195879
TEVA-DULOXETINE 60MG CAPSULE (DELAYED RELEASE) Resolved 2023-07-12 2023-11-23 198391
TEVA-DULOXETINE 30MG CAPSULE (DELAYED RELEASE) Actual shortage 2023-10-05 2024-01-25 206431
TEVA-DULOXETINE 30MG CAPSULE (DELAYED RELEASE) Actual shortage 2024-01-11 2024-04-25 215751
ACT DILTIAZEM T 360MG CAPSULE (EXTENDED RELEASE) Resolved 2017-03-17 2018-10-11 3362

Showing 301 to 320 of 2654

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64626
RATIO-ATORVASTATIN Discontinued 2018-10-19 2018-10-19 64852
ACT CLOPIDOGREL Discontinued 2018-10-19 2018-10-19 65065
ACT TADALAFIL Discontinued 2018-10-22 2018-10-22 65284
ACT TADALAFIL Discontinued 2018-10-22 2018-10-22 65289
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81330
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81337
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81344
HYDROCORTISONE SODIUM SUCCINATE INJECTION Discontinued 2019-04-11 2019-04-11 81347
TEVA-RANITIDINE Discontinued 2020-02-13 2020-02-13 106136
TEVA-RANITIDINE Discontinued 2020-02-13 2020-02-13 106139
RATIO-SALBUTAMOL Discontinued 2020-02-13 2020-02-13 106151
GEMCITABINE FOR INJECTION Discontinued 2020-02-13 2020-02-13 106155
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106170
LINEZOLID INJECTION Discontinued 2020-02-13 2020-02-13 106173
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106176
NOVAMOXIN 500MG CAPSULE Discontinued 2017-06-27 2017-06-27 14046
RATIO-FENOFIBRATE MC 200MG CAPSULE Discontinued 2018-10-12 2018-10-12 63943
RATIO-FENOFIBRATE MC 200MG CAPSULE Discontinued 2018-10-19 2018-10-19 64891
TEVA-TECNAL C 1/4 330MG 50MG 15MG 40MG CAPSULE Discontinued 2019-04-11 2019-04-11 81353

Showing 21 to 40 of 250